Evidence map›Paper›PMID 36069923›Full record

ArticleThe Journal of experimental medicine2022

GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection.

Eduardo P Amaral, Taylor W Foreman, Sivaranjani Namasivayam, Kerry L Hilligan, Keith D Kauffman, Caio Cesar Barbosa Bomfim, Diego L Costa, Beatriz Barreto-Duarte, Clarissa Gurgel-Rocha, Monique Freire Santana and 9 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Modulation of Ferroptosis During EarlybioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Protein-Mediated Virulence in Mycobacterium tuberculosis.Advances in experimental medicine and biology · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. LncRNA-CFTBS enhancesVirulence · 2025
    Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 4 countries.

Eduardo P AmaralImmunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD.ORCID 0000-0001-5465-8113
Taylor W ForemanT Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD.ORCID 0000-0003-2968-9019
Sivaranjani NamasivayamImmunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD.ORCID 0000-0001-9993-1347
Kerry L HilliganImmunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD.ORCID 0000-0003-1238-1552
Keith D KauffmanT Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD.ORCID 0000-0001-7208-1565
Caio Cesar Barbosa BomfimImmunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD.ORCID 0000-0003-1998-9237
Diego L CostaDepartmento de Bioquímica e Imunologia, Programa de Pós-Graduação em Imunologia Básica e Aplicada, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.ORCID 0000-0002-9440-2814
Beatriz Barreto-DuarteLaboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.ORCID 0000-0002-9901-8328
Clarissa Gurgel-RochaDepartment of Pathology, School of Medicine of the Federal University of Bahia, Salvador, Bahia, Brazil.ORCID 0000-0001-8922-2985
Monique Freire SantanaDepartmento de Ensino e Pesquisa, Fundação Centro de Controle de Oncologia do Estado do Amazonas, Manaus, Brazil.ORCID 0000-0001-7849-6112
Marcelo Cordeiro-SantosFundação Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Brazil.ORCID 0000-0002-7140-7145
Elsa Du BruynWellcome Centre for Infectious Disease Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-5088-2158
Catherine RiouWellcome Centre for Infectious Disease Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.ORCID 0000-0001-9679-0745
Kate AbermanImmunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD.ORCID 0000-0001-9064-1319
Robert John WilkinsonWellcome Centre for Infectious Disease Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-2753-1800
Daniel L BarberT Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD.ORCID 0000-0001-7008-7509
Katrin D Mayer-BarberInflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.ORCID 0000-0002-0311-3233
Bruno B AndradeLaboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.ORCID 0000-0001-6833-3811
Alan SherImmunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD.ORCID 0000-0001-7053-2895
National Institutes of Health · USUniversity of Cape Town · ZAFundação de Medicina Tropical · BRUniversidade Federal da Bahia · BRUniversidade de São Paulo · BRUniversidade Salvador · BR

Funding

Inflammatory determinants of disease severity and treatment outcome in TB patientsU01AI115940 · NIAID · UNIVERSITY OF CAPE TOWN · PI SHER, ALAN, WILKINSON, ROBERT JOHN · 2015 to 2019
$1.1M
Cancer Research UK FC0010218Conselho Nacional de Desenvolvimento Científico e TecnológicoJosé Silveira FoundationMedical Research Council FC001028NIAID NIH HHS U01 AI115940Oswaldo Cruz FoundationWellcome FC0010218Wellcome Trust
6 · The paper itself

Abstract

Cellular necrosis during Mycobacterium tuberculosis (Mtb) infection promotes both immunopathology and bacterial dissemination. Glutathione peroxidase-4 (Gpx4) is an enzyme that plays a critical role in preventing iron-dependent lipid peroxidation-mediated cell death (ferroptosis), a process previously implicated in the necrotic pathology seen in Mtb-infected mice. Here, we document altered GPX4 expression, glutathione levels, and lipid peroxidation in patients with active tuberculosis and assess the role of this pathway in mice genetically deficient in or overexpressing Gpx4. We found that Gpx4-deficient mice infected with Mtb display substantially increased lung necrosis and bacterial burdens, while transgenic mice overexpressing the enzyme show decreased bacterial loads and necrosis. Moreover, Gpx4-deficient macrophages exhibited enhanced necrosis upon Mtb infection in vitro, an outcome suppressed by the lipid peroxidation inhibitor, ferrostatin-1. These findings provide support for the role of ferroptosis in Mtb-induced necrosis and implicate the Gpx4/GSH axis as a target for host-directed therapy of tuberculosis.

Indexed as

FerroptosisTuberculosisAnimalsGlutathioneGlutathione PeroxidaseLipid PeroxidationMiceMice, TransgenicNecrosisPhospholipid Hydroperoxide Glutathione PeroxidaseGlutathioneGlutathione PeroxidasePhospholipid Hydroperoxide Glutathione Peroxidaseselenium-independent glutathione peroxidase

Identifiers

PMID36069923
PMCPMC9458471
OpenAlexW4294919856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.